Concord Drugs Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹37.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 123.07 per cent from ₹16.99 crore. This corresponds to a year-on-year *(YoY) growth of 264.77 per cent.
Operating Profit
Operating Profit stands at ₹1.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 59.57 per cent from ₹0.94 crore. This corresponds to a year-on-year *(YoY) growth of 44.23 per cent.
PBDT
PBDT stands at ₹1.10 crore, reflecting a quarter-on-quarter *(QoQ) increase of 80.33 per cent from ₹0.61 crore. This corresponds to a year-on-year *(YoY) growth of 150.00 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.75 crore, reflecting a quarter-on-quarter *(QoQ) increase of 150.00 per cent from ₹0.30 crore. This corresponds to a year-on-year *(YoY) growth of 1,150.00 per cent.
Net Profit
Net Profit stands at ₹0.53 crore, reflecting a quarter-on-quarter *(QoQ) increase of 140.91 per cent from ₹0.22 crore. This represents a 1,225.00 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Concord Drugs Ltd Earnings
- YOY
- QOQ
Concord Drugs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Concord Drugs Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Concord Drugs Ltd Financial Reports
Concord Drugs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Concord Drugs | -3.36% | -3.50% | -2.64% | 9.18% | -12.08% | 158.13% |
| Tyche Industries | 4.53% | -0.51% | -11.04% | 18.22% | 6.55% | -9.39% |
| Godavari Drugs | 4.01% | -2.51% | -5.00% | 47.17% | 68.67% | 24.24% |
| Pharmaids Pharma | 1.61% | 6.71% | -5.45% | -9.56% | -42.08% | -50.44% |
| Denis Chem Lab | 1.31% | 2.40% | -3.01% | 8.03% | -6.81% | -28.24% |
| Mercury Labs | 4.57% | -0.33% | 2.02% | -3.13% | -7.25% | -7.63% |
| Makers Labs. | 10.46% | 6.59% | 0.38% | 1.29% | 30.33% | 1.75% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : S Nagi Reddy
ED / WTD / CFO / Promoter : Koni Reddy
WTD & Executive Director : S. Manoj Kumar Reddy
Independent Non Exe. Director : K Ramchandra Reddy
Independent Non Exe. Director : Summela Kasu
Independent Non Exe. Director : S. Nagavenkata Hareesh
Independent Non Exe. Director : Satyam Reddy Gopidi
Company Sec. & Compli. Officer : Namratha